Table 2

Reasons underlying unwillingness or hesitation to be vaccinated against pandemic H1N1 (n, %)

Reasons of unwillingness or hesitation

Will not be vaccinated

Indecisive

Total


Possible side effects

267 (74.8)

251 (82.0)

518 (78.1)

Lack of comprehensive field evaluation before marketing

266 (74.5)

241 (78.8)

507 (76.5)

Implementation in our country before wide implementation in other countries

199 (55.9)

184 (60.1)

383 (57.9)

Vaccines which will be administered here are different than the vaccines in the US

153 (42.9)

137 (44.9)

290 (43.8)

Do not have trust in the effectiveness of the vaccine

157 (44.0)

114 (37.3)

271 (40.9)

Do not trust Ministry of Health's practices

147 (41.2)

104 (34.0)

251 (37.9)

Due to the risk of acquiring H1N1 following vaccination

71 (19.9)

66 (21.6)

137 (20.7)

The disease is mild

59 (16.5)

34 (11.1)

93 (14.0)

Contracting the disease is safer

34 (9.5)

13 (4.2)

47 (7.1)

Other

30 (8.4)

15 (4.9)

45 (6.8)


Arda et al. BMC Infectious Diseases 2011 11:87   doi:10.1186/1471-2334-11-87

Open Data